SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-23-202349
Filing Date
2023-08-03
Accepted
2023-08-03 08:45:02
Documents
14
Period of Report
2023-08-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d518119d8k.htm   iXBRL 8-K 28240
2 EX-99.1 d518119dex991.htm EX-99.1 37194
  Complete submission text file 0001193125-23-202349.txt   235911

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA snse-20230803.xsd EX-101.SCH 3870
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE snse-20230803_def.xml EX-101.DEF 14095
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE snse-20230803_lab.xml EX-101.LAB 23424
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE snse-20230803_pre.xml EX-101.PRE 15128
8 EXTRACTED XBRL INSTANCE DOCUMENT d518119d8k_htm.xml XML 5216
Mailing Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850
Business Address 1405 RESEARCH BLVD, SUITE 125 ROCKVILLE MD 20850 (240) 243-8000
Sensei Biotherapeutics, Inc. (Filer) CIK: 0001829802 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39980 | Film No.: 231138270
SIC: 2834 Pharmaceutical Preparations